Author: Davidson Michael H
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.1, Iss.3, 2002-09, pp. : 207-212
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By McClellan K.J. Wiseman L.R. McTavish D.
Drugs, Vol. 55, Iss. 3, 1998-03 ,pp. :
By Isaacsohn J. Zinny M. Mazzu A. Lettieri J. Heller A.H.
European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. :
Controversy about the Cardiovascular Safety of Sibutramine
Drug Safety, Vol. 33, Iss. 7, 2010-07 ,pp. :
By Insull W Isaacsohn J Kwiterovich P Ma P Brazg R Dujovne C Shan M Shugrue-Crowley E Ripa S Tota R
The Journal of International Medical Research, Vol. 28, Iss. 2, 2000-03 ,pp. :